Type IIType II DiabetesFat, BodyHeart / Stroke-RelatedResearch & DevelopmentCancerCardiovascular DiseasesHeart HealthDiabetesType 2 DiabetesGene TherapyHealth TechnologyResearch And DevelopmentNutritionBody FatPublic HealthObesity
Updated on September 22, 2022
HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
TUESDAY, March 6, 2012 (HealthDay News) -- New research offers potential insight into the connection between cancer, obesity and longevity in humans by showing that genetically modified mice live longer, skinnier and almost cancer-free lives.
There are quite a few differences between mice and humans, especially in regard to the type of fat that's apparently affected by the genetic tweak, so there's no way to know if the research could lead to benefits in humans. Even if medications based on the research are developed, no one knows what the side effects in people might be or their eventual cost.
Still, a potential drug "could have two benefits: adding some extra protection against cancer and protecting us from overeating," said Manuel Serrano, senior group leader at the Spanish National Cancer Research Center in Madrid and co-author of a study appearing in the March issue of Cell Metabolism.
At issue is a gene called Pten that boosts the body's cancer-fighting powers. Mutations in the gene can contribute to the development of cancer.
The researchers genetically engineered mice to have extra copies of the gene. The mice didn't suffer from side effects, Serrano said, and they managed to live 15 percent longer than other mice and suffer from less cancer.
He acknowledged, however, that figuring out a mouse's cause of death can be a challenge.
Mice that ate a high-fat diet also managed to be leaner, suggesting that the genetic tweak affected their ability to gain weight even when they would normally be packing on the extra ounces.
Serrano said the key seems to be the tweak's effect on something known as brown fat.
Both mice and humans have brown fat, but it's better understood in mice, he noted. In mice, it appears to burn regular "white fat" and be activated when it's cold or when the mice eat too much, Serrano said.
"Brown fat is very abundant and active in mice, but in humans it is scarce," Serrano explained. "At present, it is not known whether pushing the brown fat in humans will have a significant effect in fat burning."
Serrano said drugs are now in development that tinker with the gene in an effort to fight cancer.
Dr. Aaron Cypess, an assistant professor at Harvard Medical School who studies obesity, said the research appears to be valid and useful.
"There's a connection being made between tumor-suppressing genes, which prevent cancers from growing, and energy expenditure -- consuming calories," he said. "We know that obesity can lead to cancer in humans. This makes the arrow go the other direction. What it's saying is that no cancer leads to no obesity."
There's a big caveat, however. "While the mouse is a very useful model to understand humans, there are a lot of differences between mice and men," Cypess said. "Practically speaking, just because something happens in a mouse model doesn't mean it's going to happen in a human. We are very different."
In a related study in the journal, researchers at the University of California, Irvine, found that blocking production of a marijuana-like compound in the brain boosted mice's metabolism of brown fat. These mice were able to eat more and move less than typical mice, without gaining weight or developing symptoms that can raise the risk of diabetes and heart disease.
For more about obesity, visit the U.S. National Library of Medicine.
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at firstname.lastname@example.org with any questions.
Read this Next
Other Trending Articles